Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A

Risultato della ricerca: Contributo su rivistaArticolo in rivistapeer review

Abstract

Follenzi and colleagues show that endothelial cells can be obtained starting from blood CD34+ cells of both healthy and hemophilic donors passing through iPSC generation. During the differentiation process the cells can be genetically modified by LV to express FVIII; corrected endothelial cells secrete FVIII in vitro and ameliorate the hemophilic phenotype in a mouse model of the disease.

Lingua originaleInglese
pagine (da-a)1391-1406
Numero di pagine16
RivistaStem Cell Reports
Volume11
Numero di pubblicazione6
DOI
Stato di pubblicazionePubblicato - 11 dic 2018

Fingerprint

Entra nei temi di ricerca di 'Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A'. Insieme formano una fingerprint unica.

Cita questo